Literature DB >> 8440393

Purification and characterization of the trefoil peptide human spasmolytic polypeptide (hSP) produced in yeast.

L Thim1, K Norris, F Norris, P F Nielsen, S E Bjørn, M Christensen, J Petersen.   

Abstract

Recombinant human spasmolytic polypeptide (r-hSP) has been produced in relatively large amounts in Saccharomyces cerevisiae. The two intronless trefoil domains of the hSP-DNA were cloned separately by PCR from human genomic DNA, and the remaining parts of the gene synthesized. Recombinant plasmids were constructed to encode a fusion protein consisting of a hybrid leader sequence and the hSP sequence. The leader sequence serves to direct the fusion protein into the secretory pathway of the cell and to expose it to the Kex 2 processing enzyme system. The secreted r-hSP was found in a glycosylated and an non-glycosylated form. The two forms of r-hSP were purified from the yeast fermentation broth by a combination of ion-exchange chromatography and preparative HPLC. The overall yield from 8 litres of fermentation broth was 160 mg r-hSP and 219 mg glycosylated r-hSP corresponding to 50% and 34%, respectively. The structure of the r-hSP and the glycosylated r-hSP was determined by amino acid analysis and carbohydrate composition analysis as well as by peptide mapping, amino acid sequencing and mass spectrometric analysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440393     DOI: 10.1016/0014-5793(93)80543-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in gastric juice.

Authors:  J I Semple; J L Newton; B R Westley; F E May
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

Review 2.  Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Authors:  Nayara Braga Emidio; Stuart M Brierley; Christina I Schroeder; Markus Muttenthaler
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-09

3.  Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis.

Authors:  C P Tran; G A Cook; N D Yeomans; L Thim; A S Giraud
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

4.  Systemically administered trefoil factors are secreted into the gastric lumen and increase the viscosity of gastric contents.

Authors:  S Kjellev; E Nexø; L Thim; S S Poulsen
Journal:  Br J Pharmacol       Date:  2006-07-31       Impact factor: 8.739

5.  Distribution and metabolism of intravenously administered trefoil factor 2/porcine spasmolytic polypeptide in the rat.

Authors:  S S Poulsen; J Thulesen; E Nexø; L Thim
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

6.  Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells.

Authors:  J A Efstathiou; D Liu; J M Wheeler; H C Kim; N E Beck; M Ilyas; A J Karayiannakis; N J Mortensen; W Kmiot; R J Playford; M Pignatelli; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

7.  The human two domain trefoil protein, TFF2, is glycosylated in vivo in the stomach.

Authors:  F E May; J I Semple; J L Newton; B R Westley
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

8.  Expression of trefoil peptides pS2 and human spasmolytic polypeptide in gastric metaplasia at the margin of duodenal ulcers.

Authors:  S Khulusi; A M Hanby; J M Marrero; P Patel; M A Mendall; S Badve; R Poulsom; G Elia; N A Wright; T C Northfield
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

9.  Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway.

Authors:  A Dignass; K Lynch-Devaney; H Kindon; L Thim; D K Podolsky
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

10.  A variant form of the human deleted in malignant brain tumor 1 (DMBT1) gene shows increased expression in inflammatory bowel diseases and interacts with dimeric trefoil factor 3 (TFF3).

Authors:  Jens Madsen; Grith Lykke Sorensen; Ole Nielsen; Ida Tornøe; Lars Thim; Claus Fenger; Jan Mollenhauer; Uffe Holmskov
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.